Biostatiq ApS: Financial statements 2024
CVR: 40966285
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Biostatiq ApS (CVR 40966285) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 85,263 and a net result of DKK -4,883 compared with DKK -875 the year before. That is a decrease of 79.6% compared with the year before. Equity in the 2024 report amounted to DKK 52,176. The solvency ratio was 52%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 85,263
- Profit/Loss
- DKK -4,883
- Equity
- DKK 52,176
- Total Assets
- DKK 100,258
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 85 t. | -5 t. | 52 t. | 1 |
| 2023 | - | 417 t. | -875 | 57 t. | 1 |
| 2022 | - | 102 t. | 73 t. | 58 t. | 0 |
| 2021 | - | -8 t. | -21 t. | -16 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Biostatiq ApS has published its annual report for 2023. Gross profit came to DKK 417,366, and the net result was DKK -875.
About Biostatiq ApS
Biostatiq ApS is a Danish company of the type Anpartsselskab based in Gilleleje, founded in 2019. The company is registered under the industry Fremstilling af andet elektrisk udstyr. The company was previously named Stealth Induction ApS. The management consists of Carsten Dan Petersen. The company is owned by Frank Friis Nielsen and Arkenstone Capital ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 808,404 and a net result of DKK 247,002 compared with DKK -4,883 the year before. Equity in the 2025 report amounted to DKK 299,178.